Certara, Inc. (CERT) vs Inhibrx Biosciences Inc. (INBX)

A side-by-side comparison of Certara, Inc. and Inhibrx Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CERT vs INBX

growth of $100 · dividends reinvested · last 6y
CERT -73.6% (-19.9%/yr)INBX +159.3% (+17.2%/yr)INBX compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120222023202420252026$26$259
CERT INBX

CERT vs INBX: by the numbers

  • •CERT is the larger company ($1.48B vs $1.41B market cap).
  • •Both run net losses; CERT's is the smaller (-16.75% vs -10773.46% net margin).

Metrics side by side

Valuation

MetricCERTINBX
Forward P/E27.89N/A
P/S ratio3.62N/A
P/B ratio1.53N/A
EV / EBITDA26.85N/A
FCF yield4.17%N/A

Profitability

MetricCERTINBX
Gross margin58.33%-91.00%
Operating margin1.86%-10386.54%
Net margin-16.75%-10773.46%
ROE-7.08%N/A
ROIC0.59%-99.35%

Growth (annualized)

MetricCERTINBX
Revenue CAGR (5Y)9.31%N/A
FCF CAGR (5Y)8.78%N/A
Total return CAGR (5Y)-21.31%27.64%

Frequently asked

How have CERT and INBX total returns compared?
Over the past 5 years, CERT delivered -21.31% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.